Wu Xiaobin — SEC Form 4 filings
SEC reporting owner CIK 1739452. 24 Form 4 filings on record with FilingPulse; latest filed 2026-08-27.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-06-07 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 74 legs across 21 filings — 291,335 shares, $80,982,997 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 28,253 shares @ $280.31 ($7,919,638) in BeOne Medicines Ltd., filed 2025-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | President and COO | 24 | — | 74 legs · 291,335 sh · $80,982,997 | 29 |
Form 4 filings — Wu Xiaobin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-27 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 280 @ $380 | EDGAR |
| 2026-06-25 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,292 @ $276.26 | EDGAR |
| 2026-06-18 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,357 @ $266.76 | EDGAR |
| 2026-06-15 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 118,625 @ $0 · Sale (S): 626 @ $261.20 · Grant/award (A): 229,775 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,444 @ $269.33 · Sale (S): 40 @ $270.55 | EDGAR |
| 2026-03-10 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 168,922 @ $0 · Grant/award (A): 78,624 @ $0 | EDGAR |
| 2025-11-19 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 3,155 @ $380.23 · Sale (S): 826 @ $381.19 · Sale (S): 10 @ $382.32 | EDGAR |
| 2025-11-14 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 500 @ $350.44 · Sale (S): 3,240 @ $351.41 · Sale (S): 789 @ $352.78 · Sale (S): 251 @ $354.20 · Sale (S): 120 @ $355 · Sale (S): 100 @ $357.43 · +4 more | EDGAR |
| 2025-08-15 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 22,773 @ $174.43 · Option exercise (M): 27,085 @ $155.68 · Sale (S): 8,900 @ $300.33 · Sale (S): 4,500 @ $301.49 · Sale (S): 5,800 @ $302.45 · Sale (S): 3,517 @ $303.54 · +18 more | EDGAR |
| 2025-06-25 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,363 @ $260 | EDGAR |
| 2025-06-18 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,443 @ $265.47 · Sale (S): 100 @ $266.22 · Sale (S): 630 @ $250.87 | EDGAR |
| 2025-06-12 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 123,370 @ $0 · Grant/award (A): 232,245 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 400 @ $250.74 · Sale (S): 500 @ $251.85 · Sale (S): 400 @ $253.50 · Sale (S): 400 @ $255.31 · Sale (S): 234 @ $255.77 | EDGAR |
| 2025-04-03 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 16,477 @ $119.96 · Option exercise (M): 35,444 @ $174.43 · Sale (S): 28,253 @ $280.31 · Sale (S): 6,364 @ $281.67 · Sale (S): 12,221 @ $282.76 · Sale (S): 5,083 @ $283.79 · +2 more | EDGAR |
| 2025-03-18 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 0 @ $0 | EDGAR |
| 2025-03-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 103,883 @ $0 · Option exercise (M): 7,048 @ $169.65 · Option exercise (M): 44,873 @ $119.96 · Sale (S): 17,824 @ $260.39 · Sale (S): 11,360 @ $261.61 · Sale (S): 22,537 @ $262.51 · +3 more | EDGAR |
| 2025-03-04 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 0 @ $0 | EDGAR |
| 2025-02-20 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 30,654 @ $169.65 · Sale (S): 19,576 @ $240.31 · Sale (S): 7,919 @ $241.26 · Sale (S): 3,159 @ $242.08 · Option exercise (M): 21,267 @ $169.65 · Sale (S): 21,267 @ $240.07 · +2 more | EDGAR |
| 2024-12-10 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 0 @ $0 | EDGAR |
| 2024-09-19 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 500 @ $200 · Sale (S): 4,500 @ $200.14 | EDGAR |
| 2024-09-05 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 2,032 @ $188.16 · Sale (S): 275 @ $188.97 · Sale (S): 2,275 @ $190.29 · Sale (S): 700 @ $191.20 · Sale (S): 274 @ $192.04 | EDGAR |
| 2024-06-26 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 1,036 @ $159.53 · Sale (S): 400 @ $160.38 · Sale (S): 23 @ $161.27 | EDGAR |
| 2024-06-20 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 627 @ $159.00 · Sale (S): 1,121 @ $153.66 · Sale (S): 906 @ $154.17 · Sale (S): 300 @ $155.15 · Sale (S): 300 @ $156.80 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 253,409 @ $0 · Grant/award (A): 477,386 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1739452 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →